I expect to own EVGN at some point, but I haven’t pounced yet. Fortunately, I haven't missed out on 2013 biotech-IPO boom—my ENTA position is up 67% in just over six months.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.